|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 04/28/2006 | 5:00AM | PR Newswire (US) | ADVENTRX Announces Closing of Merger With SD Pharmaceuticals | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/26/2006 | 5:00AM | PR Newswire (US) | ADVENTRX to Present Positive Thiovir Antiviral Activity Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/13/2006 | 12:00PM | PR Newswire (US) | ADVENTRX to Present at 6th Annual Fortis Bank Biotechnology Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/10/2006 | 8:00AM | PR Newswire (US) | ADVENTRX Signs Definitive Merger Agreement with SD Pharmaceuticals | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/06/2006 | 12:00PM | PR Newswire (US) | ADVENTRX to Present at BIO 2006 Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/05/2006 | 9:00AM | PR Newswire (US) | ADVENTRX Presents Positive ANX-530 Preclinical Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/03/2006 | 5:00AM | PR Newswire (US) | ADVENTRX Presents Positive Thiovir Preclinical Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/28/2006 | 5:30AM | PR Newswire (US) | ADVENTRX Announces Upcoming Scientific Conference Presentations | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/23/2006 | 1:00PM | PR Newswire (US) | ADVENTRX to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/20/2006 | 2:26PM | PR Newswire (US) | ADVENTRX Announces Thiovir Active Against H5N1 Avian Influenza Chimeric Virus Strains | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/20/2006 | 2:21PM | PR Newswire (US) | ADVENTRX to File Amended 2005 Third Quarter to Reflect Accounting for July 2005 Financing Under EITF 00-19 | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/16/2006 | 9:27PM | PR Newswire (US) | ADVENTRX Announces 2005 Fourth Quarter and Full Year Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/09/2006 | 7:30AM | PR Newswire (US) | ADVENTRX to Present at Bear Stearns Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/22/2006 | 5:47PM | PR Newswire (US) | American Stock Exchange To Trade Options On 29 Securities | AMEX:ANX | |
| 02/14/2006 | 2:00PM | PR Newswire (US) | ADVENTRX CoFactor Phase IIb Trial Surpasses 50% Enrollment Milestone | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/03/2006 | 2:00PM | PR Newswire (US) | ADVENTRX to Present at BIO CEO on February 14 | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/31/2006 | 11:30AM | PR Newswire (US) | ADVENTRX Reports Thiovir Active Against Various Influenza A Viruses in Series of Independent Preclinical Tests | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/30/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Positive Efficacy and Safety Results from CoFactor Phase II Clinical Trial | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/23/2006 | 10:00AM | PR Newswire (US) | ADVENTRX Thiovir Preclinical Studies Slated for Presentation at HIV Pathogenesis Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/19/2006 | 10:00AM | PR Newswire (US) | Results From ADVENTRX Vinorelbine Preclinical Studies Accepted for Presentation at AACR Annual Meeting | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/17/2006 | 11:00AM | PR Newswire (US) | ADVENTRX to Present CoFactor Phase II Data at ASCO Gastrointestinal Cancer Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/07/2005 | 10:00AM | PR Newswire (US) | ADVENTRX Announces Positive FDA Pre-IND Meeting Outcome | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/01/2005 | 8:30AM | PR Newswire (US) | ADVENTRX to Present at Informed Investors Bay Area Biotechnology and Healthcare Forum | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/14/2005 | 6:18PM | PR Newswire (US) | ADVENTRX Announces 2005 Third Quarter Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/02/2005 | 8:02AM | PR Newswire (US) | ADVENTRX to Present at November Conferences | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/21/2005 | 8:30AM | Business Wire | ADVENTRX Announces Positive CoFactor Study Data at AACR Special Conference in Cancer Research | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/13/2005 | 10:30AM | Business Wire | ADVENTRX to Present at the BIO InvestorForum 2005 on October 19 | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/10/2005 | 9:30AM | Business Wire | ADVENTRX Reports Patient Enrollment Progress With CoFactor Phase IIb Trial | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/06/2005 | 9:30AM | Business Wire | ADVENTRX Reports Phase II CoFactor Trial Update | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/04/2005 | 9:30AM | Business Wire | ADVENTRX Acquires Additional Oncology Drug Through Exclusive License Agreement | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|